Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669461 | SCV000794215 | likely pathogenic | Hereditary spastic paraplegia 15 | 2017-09-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003588665 | SCV004344472 | pathogenic | Spastic paraplegia | 2023-06-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 553921). This variant has not been reported in the literature in individuals affected with ZFYVE26-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val876*) in the ZFYVE26 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZFYVE26 are known to be pathogenic (PMID: 18394578, 19805727). |
Fulgent Genetics, |
RCV000669461 | SCV005633486 | likely pathogenic | Hereditary spastic paraplegia 15 | 2024-03-21 | criteria provided, single submitter | clinical testing |